Para a página inicial

Como funciona

Transformámos a busca por clínica em algo simples, rápido e pessoal.
Responda algumas perguntasPreencha um pequeno formulário para nos contar sobre sua condição e necessidades médicas.
Receba ofertas personalizadas3 clínicas, escolhidas com base nas respostas, fornecem planos de tratamento e orçamentos personalizados.
Escolha a melhor opçãoCompare ofertas e escolha a clínica que mais atende às suas necessidades.
Também é possível ver todas as 8 clínicas abaixo..
820К+ pacientes receberam assistência desde 2014
50 países
1,500 clínicas
6K+ avaliações
3K+ médicos qualificados

Qual é o custo para procedimentos de diagnóstico e tratamento de Linfoma de Hodgkin em Israel? Descubra agora

O preço médio para diagnóstico e tratamento de Linfoma de Hodgkin em Israel é $2,000, o preço mínimo é $1,200 e o máximo é $2,800.
IsraelTurquiaÁustria
Quimioterapia para cancro da mamade $22,500de $1,200de $15,000
Quimioterapiade $2,400de $2,430de $2,500
Imunoterapia com Keytruda (Pembolizumab)de $9,800de $3,300de $15,000
Terapia de radiação para o cancro colorretal-de $7,000de $12,000
Terapia biológica-de $5,500de $20,000
Dados verificados pela Bookimed em June 2026, com base em solicitações de pacientes e cotações oficiais de 79 clínicas em todo o mundo. Os custos medianos são baseados em faturas reais (2025–2026) e atualizados mensalmente. Os preços reais podem variar.

Descubra as Melhores Clínicas de Linfoma de Hodgkin em Israel: 8 opções verificadas e preços

As clínicas são classificadas pelo sistema inteligente da Bookimed, com análise de ciência de dados em 5 critérios principais.
Sourasky Medical Center (Ichilov)
Centro Médico Sheba
Rambam Medical Center
3.6
Preço sob consulta
Página da clínica
Hadassah Medical Center

Obtenha uma Avaliação Médica para Linfoma de Hodgkin em Israel: Consulte agora com 19 médicos experientes

Ver todos os médicos
verificado

Ram Ron

24 anos de experiência

Chefe do Departamento de Hematologia do Sourasky Medical Center, liderando a equipe do hospital no tratamento do câncer de sangue.

  • Mais de 25 anos de experiência como hematologista
  • Especialização realizada no prestigiado Ronald O Perelman e Claudia Cohen Centre
  • Especializado em cancros do sangue, como o linfoma de Hodgkin
  • Licenciado em medicina pela Universidade de Mysore
verificado

Ron Ram

24 anos de experiência

Realizou centenas de transplantes de células estaminais – o Dr. Ram é especialista em casos complexos que requerem este procedimento avançado no Sourasky Medical Center.

  • Certificado em hematologia, oncologia médica e medicina interna
  • Autor de mais de 30 artigos científicos e de um capítulo de um livro de medicina
  • Concluiu a sua especialização no New York Medical College e no Westchester Medical Center
  • Concentrar-se exclusivamente em cancros hematológicos
verificado

Ronit El Hasid

38 anos de experiência

A Dra. Ronit El Hasid realizou mais de 300 transplantes pediátricos de medula óssea e sangue do cordão umbilical, chefiando o departamento no Hospital Infantil Dana Dwek de Sourasky.

  • Especializar-se em oncologia pediátrica com foco em procedimentos de transplante
  • Publicar mais de 50 artigos de pesquisa e 40 relatórios de conferências
  • Formar-se no City of Hope Hospital em Los Angeles
  • Membro das sociedades de hematologia americana e israelense
verificado

Amos Toren

43 anos de experiência

Prof. Amos Toren, MD, PhD, MHA, is a pediatric hemato-oncologist and BMT specialist. He served as Director of Pediatric Hemato-Oncology and BMT at Sheba Medical Center.

He is board certified in Pediatrics, Pediatric Hemato-Oncology, and Bone Marrow Transplantation. He holds a PhD in Human Genetics. He was Head of the Hematology Division at Tel Aviv University for two terms. He is a member of ASH, COG, ESPHI, EBMT, and CIBMTR. He also serves on the Ministry of Health Cord Blood Committee.

He led one of Israel’s most advanced pediatric oncology and BMT programs. The program treated children and young adults. His focus includes leukemia and lymphoma, immunodeficiencies, and rare cancers. He specializes in BMT and CAR T-cell therapy.

His translational research covers CAR T cells, cytokine-induced killer cells, pediatric brain tumors, and targeted therapies. He has worked with St. Anna, the NIH, and St. Jude. His publications include studies on pediatric SCT prophylaxis and PARP resistance.

Avaliações sobre Bookimed: descubra percepções de pacientes

Todas as avaliações
Mr.Ciorba • Consulta Online com Oncologista
Roménia
18 de fev. de 2020
Avaliação verificada.
Tive um ótimo resultado com meu tratamento e estou muito satisfeito com o resultado
Muito profissional e orientado para o paciente
Sobre o serviço Bookimed
Sim

Compartilhar este conteúdo

Histórias em vídeo de pacientes da Bookimed

Dayana
I combined my vacation in Antalya with a check-up.
Procedimento: Check-up feminino
Igor
It was great! Transfers, accommodation, treatment—all included.
Procedimento: Implante Dentário
Clínica: WestDent Clinic
Marina
Bookimed did everything for me. I didn't have to worry about anything.
Procedimento: Check-up feminino
Atualizado: 02/18/2020
Autoria de
Anna Leonova
Anna Leonova
Chefe da Equipe de Marketing de Conteúdo
Redator médico certificado com mais de 10 anos de experiência, desenvolveu o conteúdo confiável do Bookimed, apoiado por Mestrado em Filologia e entrevistas com especialistas médicos em todo o mundo.
Fahad Mawlood
Editor médico e cientista de dados
Clínico geral. Vencedor de 4 prêmios científicos. Atuou na Ásia Ocidental. Ex-líder de equipe médica que atendia pacientes de língua árabe. Agora responsável pelo processamento de dados e precisão do conteúdo médico.
Fahad Mawlood Linkedin
Esta página pode conter informações relacionadas a várias condições médicas, tratamentos e serviços de saúde disponíveis em diferentes países. O conteúdo é fornecido apenas para fins informativos e não deve ser interpretado como orientação ou aconselhamento médico. Consulte um médico ou profissional de saúde qualificado antes de iniciar ou alterar qualquer tratamento médico.

FAQ sobre Tratamento de Linfoma de Hodgkin em Israel

Estas Perguntas Frequentes provêm de pacientes reais que procuram assistência médica através da Bookimed. As respostas são dadas por coordenadores médicos experientes e representantes de confiança das clínicas.

What are the success rates for Hodgkin's lymphoma treatment in Israel?

Israel reports exceptional Hodgkin lymphoma success rates, including a 100% one-year survival for patients using innovative chemo-biologic protocols. Clinics maintain a 90% average oncology success rate. Specialized centers achieve a 95% complete response rate using advanced chemotherapy and targeted biological therapy combinations.

  • Complete response rate: Israeli protocols achieve 95% response with rapid disease control within nine weeks.
  • Long-term survival: Standard ABVD frontline therapy delivers a 93.6% overall survival rate for 30 months.
  • Pediatric outcomes: Short-term survival for pediatric patients is 96.6% at leading Israeli medical centers.
  • Specialized techniques: PET-guided protocols and CAR-T therapies boost results for hard-to-treat or relapsed cases.

Bookimed Expert Insight: Israeli oncology centers like Sheba Medical Center and Sourasky prioritize rapid adaptation based on diagnostic data. Experts like Dr. Abraham Avigdor use PET-CT scans after just two chemotherapy cycles to measure response. If the disease persists, they immediately switch to salvage therapies or clinical trials. This proactive approach explains why Israeli centers report higher remission rates than the global average.

Patient Consensus: Patients note that fertility preservation is a routine part of the process and usually covered. Many emphasize how the clean, well-run environment at clinics like Sourasky makes their treatment journey easier.

What innovative treatments are available in Israel?

Israel offers advanced medical innovations like home-grown CAR-T cell therapy and TIL immunotherapies for hematologic cancers. Facilities like Sheba Medical Center and Sourasky Medical Center provide targeted drug treatments including Keytruda. Precise PET/CT-based prognostics help doctors tailor protocols for Hodgkin lymphoma and other complex conditions.

  • Cellular therapy: Locally manufactured CAR-T cell therapy treats blood cancers and lymphomas.
  • Cryoablation systems: ProSense technology uses liquid nitrogen to freeze and destroy solid tumors.
  • Bone marrow transplant: Specialized centers perform allogeneic transplants and stem cell procedures.
  • Regenerative implants: FDA-approved Agili-C implants promote natural cartilage and bone regeneration.

Bookimed Expert Insight: Israeli oncology centers like Sourasky Medical Center maintain a 90% success rate by integrating research directly into clinical practice. Dr. Fredi Aviv has over 30 years of experience specifically in oncohematology clinical trials at this facility. Patients benefit from doctors who personally develop the protocols they administer.

Patient Consensus: Patients note it is important to choose JCI-accredited hospitals that offer all-inclusive support for smooth communication. Many highlight that local CAR-T options provide accessible alternatives to expensive international commercial drugs.

Which hospitals are considered leading centers for Hodgkin’s lymphoma care in Israel?

Israel is a global leader in Hodgkin lymphoma care. Major centers like Sheba Medical Center and Sourasky Medical Center offer advanced treatments. These include CAR T-cell therapy and bone marrow transplants. Facilities maintain Joint Commission International accreditation and high success rates.

  • Sheba Medical Center: Ranked among the top 10 hospitals worldwide by Newsweek for 2025.
  • Sourasky Medical Center: Reports a 90% success rate for oncology treatments in Tel Aviv.
  • Hadassah Medical Center: Specializes in pediatric oncohematology and bone marrow transplantation in Jerusalem.
  • Rambam Medical Center: Acclaimed for collaboration with global groups like the European Society.

Bookimed Expert Insight: While Sheba is famous for Newsweek rankings, Sourasky serves 1,800,000 patients yearly with 2,200 doctors. This high volume allows specialists like Dr. Fredi Aviv to focus only on blood cancers. Choosing these high-capacity centers often provides faster access to multidisciplinary teams.

Patient Consensus: Patients note that major centers like Sheba provide faster access to PET scans and immunotherapy than many Western hospitals. They emphasize the importance of English-speaking coordinators who help navigate the system without bureaucracy.

How long does a standard treatment course take?

Standard Hodgkin lymphoma treatment in Israel typically lasts between 3 and 12 months. This duration includes 6 cycles of chemo for early stages. Cases involving CAR-T cell therapy or bone marrow transplants require 30 days of inpatient monitoring. All treatment plans involve regular PET-CT scans for progress tracking.

  • Early-stage chemo: Standard courses often require 3 to 6 months of active therapy.
  • Advanced-stage chemo: Treatment may extend to 8 months for complex or high-risk cases.
  • Radiation therapy: If required after chemo, localized radiation adds 4 to 6 weeks.
  • Transplant monitoring: Inpatient stays for bone marrow transplants typically last 30 days.

Bookimed Expert Insight: While chemotherapy cycles are predictable, advanced immunotherapy like CAR-T cell therapy offered at Sheba Medical Center follows a faster timeline but requires precise logistical coordination. Patients should account for a 2-week cell manufacturing period before the actual infusion. Data shows that clinics like Sourasky achieve a 90% success rate by strictly adhering to these treatment intervals without delays.

Patient Consensus: Patients note that low blood counts or minor infections can easily extend the timeline by 1 to 3 months. Many emphasize the importance of starting fertility preservation before the first cycle begins to avoid missing the window for future family planning.

What support services are provided for international patients?

Israeli medical centers provide structured support for international Hodgkin's lymphoma patients. Services include medical coordination, Jolnt Commission International (JCI) accredited safety protocols, and visa assistance. Facilities like Sheba Medical Center or Sourasky Medical Center offer dedicated international departments to manage logistics, including airport transfers and language interpretation.

  • Travel logistics: Packages often include VIP airport-to-clinic transfers for seamless arrival.
  • Clinical navigation: Dedicated teams coordinate consultations with top hematologists like Dr. Amos Toren.
  • Language support: Professional interpreters assist with medical documentation and specialist meetings.
  • Hospitalization care: Full-service stays include 24-hour nursing and meals managed by nutritionists.

Bookimed Expert Insight: Israeli hospitals often bundle extensive diagnostics into treatment packages to ensure accuracy. For instance, Sheba Medical Center includes PET/CT scans and specialist consultations within their bone marrow transplant programs. This approach eliminates the need for patients to arrange separate appointments, saving significant time during urgent treatment phases.

Patient Consensus: Patients note it's important to have a coordinator who speaks your language fluently. They often mention that having transportation pre-arranged by the clinic significantly reduces stress when arriving in a new country.

Obtenha uma consulta gratuita

Selecione a melhor forma de contato